why choose us

First received: January 25, 2023

Clinical Trial: Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Study Status: Completed

Recruit Status: RECRUITING

Condition: Treatment Resistant Depression

Study Type: INTERVENTIONAL


Official Title: A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant De

Brief Summary: Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)

Read more